<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">RSX</journal-id>
<journal-id journal-id-type="hwp">sprsx</journal-id>
<journal-id journal-id-type="nlm-ta">Reprod Sci</journal-id>
<journal-title>Reproductive Sciences</journal-title>
<issn pub-type="ppub">1933-7191</issn>
<issn pub-type="epub">1933-7205</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1933719112466307</article-id>
<article-id pub-id-type="publisher-id">10.1177_1933719112466307</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Surgical Removal of Endometrioma Decreases the NF-kB1 (p50/105) and NF-kB p65 (Rel A) Expression in the Eutopic Endometrium During the Implantation Window</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Celik</surname>
<given-names>Onder</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1933719112466307">1</xref>
<xref ref-type="corresp" rid="corresp1-1933719112466307"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Celik</surname>
<given-names>Ebru</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1933719112466307">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Turkcuoglu</surname>
<given-names>Ilgin</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1933719112466307">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yilmaz</surname>
<given-names>Ercan</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1933719112466307">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ulas</surname>
<given-names>Mustafa</given-names>
</name>
<xref ref-type="aff" rid="aff2-1933719112466307">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Simsek</surname>
<given-names>Yavuz</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1933719112466307">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Karaer</surname>
<given-names>Abdullah</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1933719112466307">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Celik</surname>
<given-names>Nilufer</given-names>
</name>
<xref ref-type="aff" rid="aff3-1933719112466307">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Aydin</surname>
<given-names>Nasuhi Engin</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff4-1933719112466307">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ozerol</surname>
<given-names>Ibrahim</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff5-1933719112466307">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Unlu</surname>
<given-names>Cihat</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff6-1933719112466307">6</xref>
</contrib>
</contrib-group>
<aff id="aff1-1933719112466307">
<label>1</label>Department of Obstetric and Gynecology, Inonu University, School of Medicine, Malatya, Turkey</aff>
<aff id="aff2-1933719112466307">
<label>2</label>Department of Physiology, Firat University, School of Medicine, Elazig, Turkey</aff>
<aff id="aff3-1933719112466307">
<label>3</label>Department of Biochemistry, Malatya State Hospital, Malatya, Turkey</aff>
<aff id="aff4-1933719112466307">
<label>4</label>Department of Pathology, Inonu University, School of Medicine, Malatya, Turkey</aff>
<aff id="aff5-1933719112466307">
<label>5</label>Department of Microbiology, Inonu University, School of Medicine, Malatya, Turkey</aff>
<aff id="aff6-1933719112466307">
<label>6</label>Department of Obstetric and Gynecology, Acibadem University, School of Medicine, Istanbul, Turkey</aff>
<author-notes>
<corresp id="corresp1-1933719112466307">Onder Celik, Department of Obstetrics and Gynecology, Inonu University, Turgut Ozal Medical Center, 44069, Malatya, Turkey Email: <email>oncelik@inonu.edu.tr</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>7</month>
<year>2013</year>
</pub-date>
<volume>20</volume>
<issue>7</issue>
<fpage>762</fpage>
<lpage>770</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Society for Gynecologic Investigation</copyright-holder>
</permissions>
<abstract>
<p>We aimed to investigate whether the surgical removal of endometrioma alters the nuclear factor-kappa B1 (NF-kB1; p50/105) and NF-kB p65 (Rel A) expression in the eutopic endometrium of infertile women with endometrioma before and after laparoscopic removal of the ovarian endometrioma during the mid-secretory phase. Infertile women with endometrioma (n = 15) were enrolled. Infertile patients with nonendometriotic ovarian cyst (n = 10) and healthy fertile women (n = 10) were recruited as controls. Endometrial samples were obtained before and 3 months after the laparoscopic cystectomy. The NF-kB1 (p50/105) levels were analyzed by enzyme-linked immunosorbent assay (ELISA) in the endometrium of all groups before and after laparoscopic ovarian cystectomy during implantation window. Expression of NF-kB1 (p50/105) in eutopic endometrium was significantly higher in infertile women with endometrioma compared to nonendometriotic cyst and fertile controls (<italic>P</italic> &lt; .05). Laparoscopic cystectomy resulted in a significant decrease in NF-kB1 expression in women with endometrioma. The NF-kB p65 (Rel A) immunoreactivity of eutopic endometrium decreased significantly subsequent to the surgical removal of the endometrioma. In conclusion, increased endometrial NF-kB expression may contribute to endometriosis-associated infertility.</p>
</abstract>
<kwd-group>
<kwd>endometrioma</kwd>
<kwd>eutopic endometrium</kwd>
<kwd>laparoscopy</kwd>
<kwd>NF-kB1</kwd>
<kwd>NF-kB p65 (Rel A)</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1933719112466307">
<title>Introduction</title>
<p>Endometriosis is a common gynecological disease affecting approximately 6% to 10% women of reproductive aged.<sup>
<xref ref-type="bibr" rid="bibr1-1933719112466307">1</xref>,<xref ref-type="bibr" rid="bibr2-1933719112466307">2</xref>
</sup> Infertility is one of the common presentations of endometriosis, affecting 30% to 50% of cases.<sup>
<xref ref-type="bibr" rid="bibr3-1933719112466307">3</xref>
</sup> The underlying mechanisms of endometriosis-associated infertility remain elusive.<sup>
<xref ref-type="bibr" rid="bibr4-1933719112466307">4</xref>
</sup> The suggested mechanisms include mechanical factors, defective folliculogenesis, fertilization, and implantation as well as the low oocyte quality.<sup>
<xref ref-type="bibr" rid="bibr5-1933719112466307">5</xref>
<xref ref-type="bibr" rid="bibr6-1933719112466307"/>–<xref ref-type="bibr" rid="bibr7-1933719112466307">7</xref>
</sup> Implantation failure due to the endometrial biochemical defect during the implantation window is one of the possible mechanism underlying endometriosis associated–infertility, particularly in minimal to mild endometriosis in which the mechanical reasons do not explain the infertility.<sup>
<xref ref-type="bibr" rid="bibr4-1933719112466307">4</xref>,<xref ref-type="bibr" rid="bibr8-1933719112466307">8</xref>
</sup>
</p>
<p>The surgical excision of endometrioma in infertile women is controversial.<sup>
<xref ref-type="bibr" rid="bibr9-1933719112466307">9</xref>
</sup> Evidence indicating a decrease in the functional ovarian reserve after the surgical removal of endometrioma has been accumulating.<sup>
<xref ref-type="bibr" rid="bibr10-1933719112466307">10</xref>,<xref ref-type="bibr" rid="bibr11-1933719112466307">11</xref>
</sup> Despite the decreased ovarian reserve after the surgery, the pregnancy rate achieved with in vitro fertilization (IVF) was found similar to IVF cycles conducted for tubal factor infertility.<sup>
<xref ref-type="bibr" rid="bibr12-1933719112466307">12</xref>
</sup> The only prospective randomized study evaluating the effect of surgical removal of endometrioma on the IVF outcome and pregnancy rate did not find an augmentation or attenuation in the pregnancy rates.<sup>
<xref ref-type="bibr" rid="bibr10-1933719112466307">10</xref>
</sup> Nevertheless, spontaneous conception is possible in about 50% of subfertile women after the surgical removal of endometrioma, which should not be overlooked.<sup>
<xref ref-type="bibr" rid="bibr13-1933719112466307">13</xref>
</sup>
</p>
<p>Currently, inflammation and the nuclear factor-kappa B (NF-kB) pathways are the most studied process in the pathogenesis of endometriosis. Its role in the pathophysiology of endometriosis has been demonstrated by previous experimental and clinical studies.<sup>
<xref ref-type="bibr" rid="bibr14-1933719112466307">14</xref>,<xref ref-type="bibr" rid="bibr15-1933719112466307">15</xref>
</sup> Further, the NF-kB/p65 expression was found as a predictive marker for the endometriosis recurrence, identifying it as a therapeutic target to prevent recurrence.<sup>
<xref ref-type="bibr" rid="bibr16-1933719112466307">16</xref>
</sup> The invasion enzymes, matrix metalloproteinases (MMPs), urokinase-type plasminogen activator (uPA), and tissue plasminogen activator (tPA) in the endometrium have been shown to be positively regulated by NF-kB.<sup>
<xref ref-type="bibr" rid="bibr17-1933719112466307">17</xref>,<xref ref-type="bibr" rid="bibr18-1933719112466307">18</xref>
</sup> Thus, the increased NF-kB expression in eutopic endometrium of the endometriosis cases may contribute to the adhesion and invasion of the retrogradely available endometrial tissue to the peritoneum, through activating the invasion enzymes.</p>
<p>The role of NF-kB pathway in the pathophysiology of the endometriosis was further addressed in the endometriosis cases treated with the NF-kB pathway inhibitors. By using 2 different NF-kB inhibitors (pyrrolidine dithiocarbamate and bortezomib), our group has demonstrated diminished cell proliferation and angiogenesis of ectopic lesion and, therefore, a reduction in the endometriotic implant development.<sup>
<xref ref-type="bibr" rid="bibr14-1933719112466307">14</xref>
</sup>
</p>
<p>The NF-kB pathway was indicated to be active in the normal endometrium of healthy women.<sup>
<xref ref-type="bibr" rid="bibr19-1933719112466307">19</xref>
<xref ref-type="bibr" rid="bibr20-1933719112466307"/>–<xref ref-type="bibr" rid="bibr21-1933719112466307">21</xref>
</sup> However, its expression was found to be altered in the eutopic endometrium of endometriosis.<sup>
<xref ref-type="bibr" rid="bibr19-1933719112466307">19</xref>,<xref ref-type="bibr" rid="bibr22-1933719112466307">22</xref>
</sup> Nevertheless, the effect of surgical removal of endometriotic lesion on the NF-kB expression in the eutopic endometrium is unknown.</p>
<p>The NF-kB peptides construct homodimers or heterodimers from 5 subunits: p50/p105 (NF-kB1), p52/p100 (NF-kB2), p65 (RelA), c-Rel, and RelB. Rel-A/NF-kB1 heterodimer is the more commonly found in vivo, and Rel-A is the subunit that most frequently participates in the active NF-kB complex.<sup>
<xref ref-type="bibr" rid="bibr23-1933719112466307">23</xref>,<xref ref-type="bibr" rid="bibr24-1933719112466307">24</xref>
</sup> NF-kB1 (p105) and NF-kB2 (p100) are converted into p50 and p52, respectively, which can pass to the nucleus and bind to DNA for activation of gene transcription. However, p65 (Rel A) can readily translocate to the nucleus without any conversion. NF-kB dimers are located in the cell cytoplasm bound to the inhibitor of kappa B protein α (IκBα) that blocks the nuclear translocation of NF-kB. In response to an extracellular signal, NF-kB cascade is activated and IκBα is phosphorylated allowing the release of NF-kB<sup>
<xref ref-type="bibr" rid="bibr24-1933719112466307">24</xref>
<xref ref-type="bibr" rid="bibr25-1933719112466307"/>–<xref ref-type="bibr" rid="bibr26-1933719112466307">26</xref>
</sup> dimers capable of binding to DNA, translocation to the nucleus, and activation of the transcription of several target genes.<sup>
<xref ref-type="bibr" rid="bibr27-1933719112466307">27</xref>,<xref ref-type="bibr" rid="bibr28-1933719112466307">28</xref>
</sup>
</p>
<p>In the present study, we attempted to investigate whether surgical removal of endometrioma alters the NF-kB expression in the eutopic endometrium of infertile women with endometrioma. We evaluated the NF-kB1 (p50/p105) level and NF-kB p65 (Rel A) expression in the eutopic endometrium of infertile patients with endometrioma before and after laparoscopic removal of the ovarian endometrioma during the mid-secretory phase. In addition, to assess the specificity of the results, patients with other benign ovarian cyst that may have clinical, biochemical, and surgical profiles mimicking those of endometrioma should be included as controls. Thus, in the present study, infertile patients with nonendometriotic ovarian cyst and healthy fertile women were recruited as controls.</p>
</sec>
<sec id="section2-1933719112466307" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="section3-1933719112466307">
<title>Patients and Study Design</title>
<p>We evaluated the NF-kB1 (p105) subunit level and NF-kB p65 (Rel A) subunit expression in the endometrial tissues obtained prior to surgery and respective endometrial tissues after the laparoscopic ovarian cystectomy by stripping method during mid-luteal phase, in 15 infertile women with endometrioma and 10 infertile control cases with benign nonendometriotic ovarian cyst. In addition, endometrial tissues were obtained from 10 healthy fertile women with macroscopically normal pelvic cavities, who underwent laparoscopic tubal ligation or reversal of tubal sterilization before surgery during mid-luteal phase. The study protocol was approved by the institutional Ethical Committee for Research on Human Subjects. Informed written consent forms were obtained from all the participants before recruitment.</p>
<p>All of the infertile women underwent a routine laboratory and radiological examination to diagnose the underlying factors of infertility. The infertile women had normal early follicular follicle-stimulating hormone (FSH), luteinizing hormone (LH), estrogen (E2), thyroid-stimulating hormone (TSH), and prolactine (PRL) levels, and normal midluteal progesterone levels indicating the presence of ovulation, normal 2-semen analysis evaluated at least 3 weeks’ apart and upon 3 to 7 days of abstinence and normal hysterosalpingography (HSG) with bilateral tubal patency and absence of intrauterine mass forming pathology and the only detectable cause of infertility was endometrioma or otherwise unexplained. The fertile women enrolled as the control group had at least 2 children and had no history of infertility or habitual abortion.All the women recruited to the study had regular menstrual cycles, ranging between 21 and 35 days.</p>
<p>The presence of ovarian cyst was diagnosed with a transvaginal ultrasonography (Toshiba Xario, Japan) by using a 5- to 7-MHz transducer. The endometrioma was suspected when a diffuse, regular-margined cyst with a low level internal echo, indicating hemorrhagic cyst, was present for at least 2 cycles, to exclude the nonendometriotic hemorrhagic cyst. The benign nonendometriotic ovarian cysts were diagnosed in the absence of characteristic ultrasonographic appearance for malignancy. The endometrioma and nonendometriotic benign ovarian cyst diagnoses were confirmed with the pathological evaluation of the surgically removed specimen by an experienced gynecologic pathologist. Histologic classification of the specimens was as follows: endometriotic cyst in 15 cases, serous cyst in 4 cases, dermoid cyst in 4 cases, and mucinous cyst in 2 cases.</p>
<p>The surgical technique involved aspiration of the cyst content and removal of the cyst wall by stripping technique. In all the cases, we were able to remove the endometriotic cyst wall from the ovarian tissue, and none of the cases required electrolysis of the cyst wall due to the unsuccessful stripping. We did not electrolyze the superficial peritoneal endometriotic implants accompanying the endometrioma, in any of the cases. The adhesions were removed by hydrodissection and/or scissors. The cases with deep peritoneal endometriosis requiring peritoneal dissection were excluded from the study.</p>
<p>All the participants were required to meet the inclusion criteria: (1) presence of pathological diagnosis of endometrioma or other benign ovarian cyst in women who underwent laparoscopic ovarian cystectomy, (2) no hormonal medication and intrauterine contraception use within the last 6 months before enrollment to the study, and (3) absence of any systemic and/or rheumatologic disease that may lead to an inflammation.</p>
<p>Excluded cases were the ones with (1) malignant ovarian tumor diagnosed with the pathological evaluation of the specimen, (2) previous medication use, (3) bilateral tubal occlusion, (4) previous endometrial pathology such as Asherman syndrome, endometrial polyp, and/or sub-mucous fibroids, (5) diagnosis of pelvic inflammatory disease, mild peritoneal endometriosis, deep endometriosis, and hydrosalpinx at the time of the study, (6) previous history of abdominal surgery, especially of ovaries, (7) history of habitual abortion, (8) infertility etiology other than endometrioma, (9) out-of-date endometrium on the pathological evaluation of endometrium, and (10) requirement of electrolysis, in addition to stripping, of the endometriotic cyst wall due to densely adherent cyst wall underlying the ovarian tissue.</p>
</sec>
<sec id="section4-1933719112466307">
<title>Endometrial Sampling</title>
<p>All patients, independent of group, were selected for the present study on the basis of consistent histological findings, menstrual history, and serum progesterone levels. The blood samples were obtained from all participants at the time of endometrial biopsy. Endometrial samples were obtained with a Pipelle catheter (Jiyangsu Medical Materials, China) from all the participants in the mid-luteal phase of the cycle, during the implantation window. The endometrial tissue was divided into 2 sections: one was fixed in 10% formalin and embedded in a paraffin block and the other was washed 3 times with a sterile saline solution to remove blood, and stored in −80°C for future analysis. The ones with endometrioma or nonendometriotic ovarian cyst underwent a second procedure 3 months after the surgical removal of the cyst. The mid-luteal phase was calculated as 7 to 9 days after the ultrasonographic confirmation of ovulation and was confirmed by endometrial histological dating and serum progesterone levels. All menstrual cycles studied in the current study were ovulatory according to mid-luteal serum progesterone &gt;10 ng/mL. Endometrial dating was performed by an independent pathologist experienced in gynecological pathology (N.E.A.). Paraffin-embedded sections of 4 mm was stained with hematoxylin and eosin and periodic acid-Schiff stain. Then these specimens were evaluated according to the histopathological criteria of Noyes et al.<sup>
<xref ref-type="bibr" rid="bibr29-1933719112466307">29</xref>
</sup> An out-of-date biopsy was defined as a lag of ≥3 days between the chronological and the histological day.<sup>
<xref ref-type="bibr" rid="bibr30-1933719112466307">30</xref>,<xref ref-type="bibr" rid="bibr31-1933719112466307">31</xref>
</sup>
</p>
<sec id="section5-1933719112466307">
<title>NF-kB1 (p105) determination in the supernatant of endometrial tissues by enzyme-linked immunosorbent assay</title>
<p>In all patients and control participants, endometrial NF-kB1 (p105) subunit concentrations were measured by enzyme-linked immunosorbent assay (ELISA), with Alisei fully automated ELISA system (RADIM-SEAC Company, Italy). This immunoassay kit (NF-kB ELISA kit, USCN Life Sci Inc, Wuhan China, Cat No: E1824h) allows for in vitro quantitative determination of human NF-kB1 (p105) concentrations in serum, plasma, urine, tissue homogenates, cell culture supernatants, and other biological fluids. The preparation of tissue homogenates will vary depending upon the tissue type. For this assay, each endometrial sample was rinsed with 1× phosphate-buffered saline (PBS) to remove excess blood and subsequently weighted as wet weight. Then, the clean endometrial samples were homogenized in 1 mL of 1× PBS and stored overnight at a temperature ≤ −20°C. After 2 freeze–thaw cycles were performed to break the cell membranes, the homogenates were centrifuged for 5 minutes at 4000 rpm. The supernatant was stored at −80°C to avoid loss of bioactivity and contamination. The detection range of kit was 0.312 to 20 ng/mL. The intra-(within day) and inter-assay (between days) coefficients of variation for endometrial NF-kB1 (p105) were &lt;10% and &lt;12%, respectively. The results of NF-kB1 (p105) concentrations detected by immunoassay kit were divided by the weights of endometrial tissue. The results were presented as ng/mg tissue.</p>
</sec>
<sec id="section6-1933719112466307">
<title>Immunohistochemical labeling for NF-kappa B/p65 (Rel A) Ab-1</title>
<p>Four micrometer paraffin sections on poly-<sc>l</sc>-lysine–coated slides were used after drying in an oven for 1 hour at 60°C. The sections were de-waxed in xylene, rehydrated in ethanol, and incubated for 10 minutes in 3% hydrogen peroxide to block endogenous peroxidase. After washing in PBS, the sections were incubated for 8 minutes in ultra V block. The immunoreaction was performed for 60 minutes with ready-to-use NF-kappa B/p65 (Rel A) Ab-1 antibody (NeoMarkers, Labvision Corp, California). After washing in PBS, the slides were incubated with horseradish peroxidase (HRP) kit. For negative control, the endometrial tissue was incubated with nonimmune rabbit serum in place of the primary antibody. Finally, the preparations were developed in 3-Amino-9-Ethylcarbazole (AEC) chromogen counterstained with hematoxylin and mounted with aqueous mount. Third-trimester human placenta served as the positive control.</p>
<p>To evaluate the immunhistochemical NF-kB p65 (Rel A) expression in the endometrium, the H-score method was used.<sup>
<xref ref-type="bibr" rid="bibr32-1933719112466307">32</xref>
</sup> This immunohistochemical semiquantitative method consists of the percentages of positively stained cells multiplied by a weighted intensity of staining: H-score = ΣPi (<italic>i</italic> + 1), where Pi is the percentage of stained cells in each intensity category (0%-100%), and <italic>i</italic> is the intensity indicating weak (<italic>i</italic> = 1), moderate (<italic>i</italic> = 2), or strong (<italic>i</italic> = 3) staining.<sup>
<xref ref-type="bibr" rid="bibr32-1933719112466307">32</xref>,<xref ref-type="bibr" rid="bibr33-1933719112466307">33</xref>
</sup>
</p>
</sec>
</sec>
<sec id="section7-1933719112466307">
<title>Statistical Analysis</title>
<p>The normality distribution of data was performed using Kolmogorov-Smirnov test, and all variables were skewed normally. The continuous variables were analyzed by analysis of variance (ANOVA) test with post hoc Tukey procedure and Mann-Whitney <italic>U</italic> test. The categorical data were analyzed by the Pearson chi-square test. A <italic>P</italic> value &lt;.05 was considered significant. The results are expressed as mean and standard deviation (SD). The data were analyzed using the Statistical Package for Social Sciences software 19.0 for Windows package software (SPSS, Inc, Chicago, Illinois).</p>
</sec>
</sec>
<sec id="section8-1933719112466307">
<title>Results</title>
<p>The demographic characteristics of each group are presented in <xref ref-type="table" rid="table1-1933719112466307">Table 1</xref>. Each group of patients had normal body mass index. The mean size of endometrioma was also similar to the mean size of nonendometriotic cysts (<italic>P</italic> = .44). In the endometrioma group, the cysts were bilateral in 10 women and unilateral in 5 women.</p>
<table-wrap id="table1-1933719112466307" position="float">
<label>Table 1.</label>
<caption>
<p>Demographic Features of Each Group<sup>a</sup>
</p>
</caption>
<graphic alternate-form-of="table1-1933719112466307" xlink:href="10.1177_1933719112466307-table1.tif"/>
<table>
<thead>
<tr>
<th>Baseline Variable</th>
<th>Endometrioma Group (n = 15)</th>
<th>Nonendometriotic Cyst (n = 10)</th>
<th>Fertile Group (n = 10)</th>
<th>P</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age, years</td>
<td>33.0 ± 5.2</td>
<td>34.2 ± 6.4</td>
<td>33.7 ± 5.4</td>
<td>NS</td>
</tr>
<tr>
<td>Infertility duration, years</td>
<td>5.66 ± 2.25</td>
<td>5.20 ± 2.52 </td>
<td align="center">–</td>
<td>NS</td>
</tr>
<tr>
<td>Size of cysts, cm</td>
<td>7.68 ± 2.39</td>
<td>6.92 ± 2.59</td>
<td align="center">–</td>
<td>NS</td>
</tr>
<tr>
<td>Laterality, n (%)</td>
<td>
</td>
<td>
</td>
<td align="center">–</td>
<td>NS</td>
</tr>
<tr>
<td> Left side</td>
<td>6/10 (60)</td>
<td>7/10 (70)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Right side</td>
<td>4/10 (40)</td>
<td>3/10 (30)</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Bilaterality</td>
<td>5/15 (33.3)</td>
<td align="center">–</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>L/S technique, n (%)</td>
<td>
</td>
<td>
</td>
<td align="center">–</td>
<td>
</td>
</tr>
<tr>
<td> Stripping</td>
<td>15/15 (100)</td>
<td>10/10 (100)</td>
<td>
</td>
<td>1</td>
</tr>
<tr>
<td> Progesterone levels before surgery</td>
<td>14.60 ± 3.08</td>
<td>14.10 ± 2.60</td>
<td>15.8 ± 2.65</td>
<td>NS</td>
</tr>
<tr>
<td> Progesterone levels after surgery</td>
<td>13.53 ± 2.58</td>
<td>14.60 ± 4.03</td>
<td>15.8 ± 2.65</td>
<td>NS</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1933719112466307">
<p>Abbreviations: NS, nonsignificant; SD, standard deviation.</p>
</fn>
<fn id="table-fn2-1933719112466307">
<p>
<sup>a</sup> Values are presented as mean and SD unless otherwise stated.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<sec id="section9-1933719112466307">
<title>Endometrial NF-kB1 (p105) Levels in the Infertile Women With Endometrioma, Nonendometriotic Ovarian Cyst and Fertile Women</title>
<p>The endometrial NF-kB1 (p105) levels were analyzed using ELISA method. The mean NF-kB1 (p105) level was significantly higher in the eutopic endometrium of women with endometrioma before the removal of cyst compared to cases with nonendometriotic cyst and fertile cases (<italic>P</italic> &lt; .0001 and <italic>P</italic> &lt; .0001, respectively). The mean endometrial NF-kB1 (p105) levels were similar in the endometrioma cases with unilateral and bilateral endometrioma, before the surgical removal of the cysts (<italic>P</italic> = .85). Surgical removal of the endometrioma decreased the mean endometrial NF-kB1 (p105) levels to those with nonendometriotic cyst before and after the cystectomy and in fertile women, in both unilateral and bilateral endometrioma cases (<xref ref-type="table" rid="table2-1933719112466307">Table 2</xref>, <xref ref-type="fig" rid="fig1-1933719112466307">Figure 1</xref>). The mean endometrial NF-kB1 (p105) levels were similar in the nonendometriotic cyst group before the surgery and the fertile group (<italic>P</italic> = .96). The removal of cyst did not change the endometrial NF-kB1 (p105) levels in the nonendometriotic cyst group (<xref ref-type="table" rid="table2-1933719112466307">Table 2</xref>).</p>
<fig id="fig1-1933719112466307" position="float">
<label>Figure 1.</label>
<caption>
<p>The nuclear factor-kappa B1 (NF-kB1; p50/105) levels in mid-luteal endometrium from infertile women with endometrioma prior to surgery, those after surgical removal, nonendometriotic ovarian cysts prior to surgery, those after surgical removal, and in fertile women.</p>
</caption>
<graphic xlink:href="10.1177_1933719112466307-fig1.tif"/>
</fig>
<table-wrap id="table2-1933719112466307" position="float">
<label>Table 2.</label>
<caption>
<p>Comparisons of NF-kB1 Concentrations (p50/105) and H-Score of Immunohistochemical NF Kappa B/65 (RelA) Expression Among the Groups</p>
</caption>
<graphic alternate-form-of="table2-1933719112466307" xlink:href="10.1177_1933719112466307-table2.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th colspan="2">NF-kB (p50/105) concentrations (ng/mg tissue)</th>
<th>P<sub>1</sub>
</th>
<th colspan="2">H-Score of NF kappa B/65 (RelA) expression</th>
<th>P<sub>2</sub>
</th>
</tr>
<tr>
<th>
</th>
<th>Preoperative</th>
<th>Postoperative</th>
<th>
</th>
<th>Preoperative</th>
<th>Postoperative</th>
<th>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>I- Unilateral endometrioma group (n = 10)</td>
<td>0.18 ± 0.08</td>
<td>0.09 ± 0.04</td>
<td>0.046<sup>b</sup>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>II- Bilateral endometrioma group (n = 5)</td>
<td>0.22 ± 0.05</td>
<td>0.09 ± 0.08</td>
<td>0.047<sup>b</sup>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>III- Entire endometrioma group (n = 15)</td>
<td>0.19 ± 0.08</td>
<td>0.09 ± 0.06</td>
<td>&lt;0.001<sup>b</sup>
</td>
<td>3.73 ± 0.35</td>
<td>2.78 ± 0.31</td>
<td>&lt;0.001<sup>b</sup>
</td>
</tr>
<tr>
<td>IV- Nonendometriotic cyst group (n = 10)</td>
<td>0.08 ± 0.04</td>
<td>0.07 ± 0.05 </td>
<td>0.99</td>
<td>2.91 ± 0.14</td>
<td>2.67 ± 0.48</td>
<td>NS</td>
</tr>
<tr>
<td>V- Fertile group (n = 10)</td>
<td colspan="2">0.07 ± 0.06</td>
<td>NA</td>
<td>2.49 ± 0.49</td>
<td/>
<td>NA</td>
</tr>
<tr>
<td>
</td>
<td colspan="2">
<italic>P</italic> Value</td>
<td rowspan="10">
</td>
<td colspan="2">
<italic>P</italic> Value</td>
</tr>
<tr>
<td>
</td>
<td>Preoperative</td>
<td>Postoperative</td>
<td>Preoperative</td>
<td>Postoperative</td>
<td>
</td>
</tr>
<tr>
<td>I vs II</td>
<td>NS</td>
<td>NS</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>I vs IV</td>
<td>.038<sup>b</sup>
</td>
<td>NS</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>I vs V</td>
<td>.005<sup>b</sup>
</td>
<td>NS</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>II vs IV</td>
<td>.005<sup>b</sup>
</td>
<td>NS</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>II vs V</td>
<td>.001<sup>b</sup>
</td>
<td>NS</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>III vs IV</td>
<td>&lt;.0001<sup>b</sup>
</td>
<td>NS</td>
<td>&lt;.0001<sup>b</sup>
</td>
<td>NS</td>
</tr>
<tr>
<td>III vs V</td>
<td>&lt;.0001<sup>b</sup>
</td>
<td>NS</td>
<td>&lt;.0001<sup>b</sup>
</td>
<td>NS</td>
</tr>
<tr>
<td>IV vs V</td>
<td>NS</td>
<td>NS</td>
<td>NS</td>
<td>NS</td>
<td>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-1933719112466307">
<p>Abbreviations: NF-kB, nuclear factor-kappa B; SD, standard deviation; ANOVA, analysis of variance; NS, nonsignificant; NA, not applicable.</p>
</fn>
<fn id="table-fn4-1933719112466307">
<p>
<sup>a</sup> Data are presented as mean and SD. Comparisons between each outcome group with fertile group (ANOVA test with post hoc Tukey procedure for continuous variables). P<sub>1</sub> represent for comparison of NF-kB1 (p50/105) between the groups; P<sub>2</sub> represent for comparison of H-Score of immunohistochemical NF kappa B/65 (RelA) expression between the groups.</p>
</fn>
<fn id="table-fn5-1933719112466307">
<p>
<sup>b</sup> <italic>P</italic> &lt; .05.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section10-1933719112466307">
<title>Immunohistochemical Expression of NF Kappa B/p65 (Rel A) Ab-1 in the Endometrium Samples From Infertile Women With Endometrioma, Fertile Group, and Infertile Women With Nonendometriotic Ovarian Cysts</title>
<p>Immunohistochemical analysis confirmed the ELISA findings in each group. The increased NF-kB p65 (Rel A) immunoreactivity was predominantly localized to the cytoplasm of luminal and glandular epithelial cells in the endometrioma group (<xref ref-type="fig" rid="fig2-1933719112466307">Figure 2</xref>). After surgical removal of endometrioma, the mean H-score of endometrial NF-kB p65 (Rel A) expression significantly decreased to a level similar to that of the fertile group and the preoperative and postoperative levels of nonendometriotic cyst group (<italic>P</italic> = .32, <xref ref-type="table" rid="table2-1933719112466307">Table 2</xref>). Furthermore, there was no statistically significant difference in the mean H-score of endometrial NF-kB p65 (Rel A) expression between the nonendometriotic cyst group before and after the cystectomy (<italic>P</italic> = .99) and the fertile group (P=0.096).</p>
<fig id="fig2-1933719112466307" position="float">
<label>Figure 2.</label>
<caption>
<p>Immunohistochemical staining of nuclear factor (NF) kappa B/65 (Rel A) in endometrium from women with endometrioma before (A) and after (B) surgery; nonendometriotic cyst before (C) and after (D) surgery. Inlet (A) shows negative control (proliferative endometrium). Intense glandular NF kappa B/65 staining in the endometrium from women with endometrioma before surgery (A; arrows) significantly decreased after surgery (B; arrow). The intensity of glandular NF kappa B/65 staining in the endometrium from woman with nonendometriotic cyst before surgery (C; arrow) was similar after surgery (D; arrow). (E) An endometrial sample from fertile control and (F) positive control (third-trimester placenta showing circumferential cytoplasmic positivity [arrow] in the trophoblastic cells in the small villus [V]).</p>
</caption>
<graphic xlink:href="10.1177_1933719112466307-fig2.tif"/>
</fig>
</sec>
</sec>
<sec id="section11-1933719112466307">
<title>Comments</title>
<p>The current study demonstrates that the NF-kB1 (p105) levels and NF-kB p65 (Rel A) expression increase in the mid-secretory eutopic endometrium of infertile cases with endometrioma, during the implantation window. NF-kB1 (p105) levels and NF-kB p65 (Rel A) expression were, at a similar rate, high in both unilateral and bilateral endometrioma cases. One of the mechanisms responsible for infertility in our study group may be the elevated NF-kB expression in the eutopic endometrium.</p>
<p>The NF-kB pathway is one of the important pathways regulating immunity and inflammation.<sup>
<xref ref-type="bibr" rid="bibr26-1933719112466307">26</xref>
</sup> Menstruation and the implantation are mainly inflammatory processes of the endometrium. Unfortunately, only limited data are available regarding the role of the NF-kB pathway in the endometrium. The NF-kB expression was found elevated during the menstrual endometrium.<sup>
<xref ref-type="bibr" rid="bibr20-1933719112466307">20</xref>
</sup> However, its role in the endometrial receptivity is conflicting. Progesterone was found to inhibit the NF-kB pathway through increasing the IκBα (NF-kB inhibitor) messenger RNA (mRNA) expression.<sup>
<xref ref-type="bibr" rid="bibr20-1933719112466307">20</xref>
</sup> The low NF-kB expression was detected in the secretory endometrium compared to menstrual endometrium.<sup>
<xref ref-type="bibr" rid="bibr21-1933719112466307">21</xref>
</sup> Nevertheless, an NF-kB pathway intermediate, IKKβ expression, was observed high in the secretory endometrium.<sup>
<xref ref-type="bibr" rid="bibr20-1933719112466307">20</xref>
</sup> Proinflammatory signals like interleukin (IL)-1, tumor necrosis factor- α (TNF-α), and prostaglandins activate IKKβ, which in turn activates the NF-kB by releasing it from the inhibition of IκBα.<sup>
<xref ref-type="bibr" rid="bibr20-1933719112466307">20</xref>
</sup> In a previous study, administration of the NF-kB inhibitors decreased the production of endometrial receptivity markers, IL-6 and LIF.<sup>
<xref ref-type="bibr" rid="bibr19-1933719112466307">19</xref>
</sup> Thereby, NF-kB pathway playing a role in the endometrial receptivity.</p>
<p>A very recent study comparing the NF-kB expression on the proliferative, secretory, and menstrual endometrium in healthy women and women with endometriosis found the physiologic pattern of NF-kB expression altered in cases with endometriosis.<sup>
<xref ref-type="bibr" rid="bibr21-1933719112466307">21</xref>
</sup> The authors also observed that NF-kB expression was increased in secretory as well as the proliferative endometrium compared to the menstrual endometrium in women with endometriosis, while it was increased only in the proliferative endometrium of healthy women. The findings of Ponce et al<sup>
<xref ref-type="bibr" rid="bibr34-1933719112466307">34</xref>
</sup> were opposing to that of our study and González-Ramos et al’s.<sup>
<xref ref-type="bibr" rid="bibr21-1933719112466307">21</xref>
</sup> That study did not find a difference in the cytoplasmic and nuclear Rel-A levels as well as the Rel-A DNA binding in the mid-secretory eutopic endometrium of cases with endometriosis compared to fertile women without endometriosis. Nevertheless, that study conducted by Ponce et al<sup>
<xref ref-type="bibr" rid="bibr34-1933719112466307">34</xref>
</sup> consisted of a heterogenous group of endometriosis cases with an American Fertility Society (AFS) score ranging between 3 and 118. Considering the fact that only 4 or 5 women were analyzed in each proliferative, early-, mid- and late-secretory endometrium groups, early stage endometriosis cases may be analyzed in some of the groups and late stage endometriosis in the other groups. Therefore, the discrepancy between the results of our study and the results of Ponce et al’s study may be due to a grouping bias.</p>
<p>The NF-kB has been shown to interact with the progesterone receptor and inhibit its action.<sup>
<xref ref-type="bibr" rid="bibr35-1933719112466307">35</xref>
</sup> Several studies have demonstrated an attenuated or deregulated progesterone response at a molecular level in endometrium from women with endometriosis.<sup>
<xref ref-type="bibr" rid="bibr36-1933719112466307">36</xref>,<xref ref-type="bibr" rid="bibr37-1933719112466307">37</xref>
</sup> Therefore, the loss of physiologic pattern of NF-kB expression could be responsible for the progesterone resistance in the endometriosis. Nevertheless, this may also impair the endometrial receptivity.</p>
<p>Progesterone stimulus is essential for the decidualization of the endometrial stromal cells and the establishment of the endometrial receptivity.<sup>
<xref ref-type="bibr" rid="bibr38-1933719112466307">38</xref>
</sup> Progesterone influences the expression of Homeobox protein A-10 (HOXA-10) and HOXA-11 in the mid- and late-secretory endometrium.<sup>
<xref ref-type="bibr" rid="bibr39-1933719112466307">39</xref>,<xref ref-type="bibr" rid="bibr40-1933719112466307">40</xref>
</sup> The great body of evidence suggests that <italic>HOX</italic> genes are essential for endometrial growth, differentiation, and receptivity by mediating some functions of the sex steroids during each reproductive cycle.<sup>
<xref ref-type="bibr" rid="bibr41-1933719112466307">41</xref>
</sup> Nevertheless, <italic>HOX</italic> gene expression was found low in the eutopic endometrium of cases with endometriosis. One of the mechanisms underlying the decreased <italic>HOX</italic> gene expression can be progesterone resistance present in the endometriosis. Another mechanism proposed was the epigenetic changes and hypermethylation of the <italic>HOXA-10</italic> gene, resulting in decreased expression.<sup>
<xref ref-type="bibr" rid="bibr42-1933719112466307">42</xref>
<xref ref-type="bibr" rid="bibr43-1933719112466307"/>–<xref ref-type="bibr" rid="bibr44-1933719112466307">44</xref>
</sup> Evidence suggests that the chronic inflammation can lead to epigenetic changes and cancer formation.<sup>
<xref ref-type="bibr" rid="bibr45-1933719112466307">45</xref>,<xref ref-type="bibr" rid="bibr46-1933719112466307">46</xref>
</sup> Hence, chronic inflammation mediated by increased NF-kB expression in endometriosis may lead to HOXA-10 hypermethylation and interfere with endometrial receptivity.</p>
<p>Another possible mechanism can be through the interference with the prolactin gene expression in the endometrium. In a study, transcription factor binding sites for HOXA10 and HOXA11, Forkhead box protein O1 (FOXO1) as well as NF-kB were found on the 200 kb of a Eutherian-specific transposable element (MER20) dPRL enhancer region of the <italic>PRL</italic> gene, activating its expression.<sup>
<xref ref-type="bibr" rid="bibr47-1933719112466307">47</xref>
</sup> Prolactin is upregulated during decidualization and its proper regulation is essential for implantation and pregnancy.<sup>
<xref ref-type="bibr" rid="bibr48-1933719112466307">48</xref>,<xref ref-type="bibr" rid="bibr49-1933719112466307">49</xref>
</sup> Hence, nonphysiologic pattern of NF-kB expression may interfere with the <italic>PRL</italic> gene expression and may alter the implantation in women with endometriosis.</p>
<p>The current study demonstrates that after surgical removal of endometrioma in both unilateral and bilateral endometrioma, the NF-kB1 levels and NF-kB p65 expression have decreased and reached to a level similar to fertile women without any pelvic pathology. The NF-kB1 levels and NF-kB p65 expression in the eutopic endometrium of cases with nonendometriotic benign ovarian cyst were also similar to fertile women without any pelvic pathology, and the endometrial NF-kB1 levels and NF-kB p65 expression did not vary after the surgical removal of the cyst. In view of these findings, it may be assumed that the elevated NF-kB expression in the eutopic endometrium is due to the chronic inflammatory condition in the endometrioma rather than a mass effect of the cyst itself.</p>
<p>Evidence supports that a physiologic amount of inflammation is necessary for endometrial receptivity and early pregnancy implantation. However, pathologic inflammation was found to interfere with the endometrial receptivity and early pregnancy implantation. Hydrosalpinx is a typical inflammatory condition associated with a 50% reduction in implantation rates in IVF cycles.<sup>
<xref ref-type="bibr" rid="bibr50-1933719112466307">50</xref>,<xref ref-type="bibr" rid="bibr51-1933719112466307">51</xref>
</sup> The other inflammatory conditions with decreased implantation rates are polycystic ovarian syndrome, uterine polyps, and fibroids as well as the endometriosis. The expression of well-characterized endometrial receptivity genes <italic>HOXA-10</italic> and <italic>HOXA-11</italic> fails during the implantation window in cases with hydrosalpinx, polycystic ovarian syndrome (PCOS), uterine fibroids, and endometriosis.<sup>
<xref ref-type="bibr" rid="bibr40-1933719112466307">40</xref>,<xref ref-type="bibr" rid="bibr52-1933719112466307">52</xref>,<xref ref-type="bibr" rid="bibr53-1933719112466307">53</xref>
</sup> Furthermore, the expressions of various other mediators of endometrial receptivity, which are also mediated by <italic>HOX</italic> genes, such as pinopodes, αvß3 integrin, and insulin growth factor binding protein 1 (IGFBP-1), are found to be decreased in endometriosis.<sup>
<xref ref-type="bibr" rid="bibr33-1933719112466307">33</xref>,<xref ref-type="bibr" rid="bibr54-1933719112466307">54</xref>,<xref ref-type="bibr" rid="bibr55-1933719112466307">55</xref>
</sup> Since the paucity of assessment of endometrial receptivity markers before and after the removal of endometrioma in the current study, we do not know the effect of decreased NF-kB levels on the endometrial receptivity markers. However, salpingectomy upregulated the HOXA-10 expression to normal levels 4 months after the surgery.<sup>
<xref ref-type="bibr" rid="bibr56-1933719112466307">56</xref>
</sup> Thus, laparoscopic removal of endometrioma, similar to salpingectomy in hydrosalpinx, may improve the endometrium by decreasing the NF-kB levels during the implantation window. In the current study, we evaluated the endometrial NF-kB levels 3 months after the surgery. The interval necessary for the resolution of the inflammation after the treatment depends on the degree of inflammatory reaction. Nevertheless the 3 months’ interval resulted in a significant decrease in the endometrial NF-kB levels after the endometrioma removal. Therefore, this study suggests that a minimum time interval of 3 months would be enough for the evaluation of endometrium after the endometrioma surgery.</p>
<p>A limitation of the current study is that we did not evaluate the DNA binding or the inhibitor of kappa B protein (IkB) phosphorylation of NF-kB in the eutopic endometrium of cases with and without endometrioma. Therefore, increased NF-kB expression does not mean increased NF-kB activity, and we are not able to comment on whether the elevated NF-kB level and expression reflected altered gene transcription.</p>
<p>In conclusion, the current study demonstrates that the NF-kB1 levels and NF-kB p65 expression increase in the eutopic endometrium of infertile women with endometrioma during the implantation window. Laparoscopic removal of the endometrioma by stripping technique decreases the NF-kB1 levels and NF-kB p65 expression to a similar level of fertile women. The elevated NF-kB1 levels and NF-kB p65 expression in the eutopic endometrium are almost similar in women with either unilateral or bilateral endometrioma and decrease with similar rates of fertile NF-kB levels with removal of the endometrioma in both cases. It may be concluded that surgical removal of endometrioma, therefore, can be beneficial in infertile women with no other infertility etiology and may improve the eutopic endometrium.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgment</title>
<p>We appreciate Dr Barıs Otlu who allowed us to use his Molecular Microbiology Laboratory of Inonu University.</p>
</ack>
<fn-group>
<fn fn-type="conflict" id="fn1-1933719112466307">
<label>Declaration of Conflicting Interests</label>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-1933719112466307">
<label>Funding</label>
<p>The author(s) received no financial support for the research, authorship, and/or publication of this article</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1933719112466307">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Houston</surname>
<given-names>DE</given-names>
</name>
</person-group>. <article-title>Evidence for the risk of pelvic endometriosis by age, race and socioeconomic status</article-title>. <source>Epidemiol Rev</source>. <year>1984</year>;<volume>6</volume>:<fpage>167</fpage>–<lpage>191</lpage>.</citation>
</ref>
<ref id="bibr2-1933719112466307">
<label>2</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Cramer</surname>
<given-names>DW</given-names>
</name>
</person-group>. <article-title>Epidemiology of endometriosis in adolescents</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Wilson</surname>
<given-names>EA</given-names>
</name>
</person-group>, ed. <source>Endometriosis</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Alan Liss</publisher-name>, <year>1987</year>:<fpage>5</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr3-1933719112466307">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strathy</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Molgaard</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Coulam</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Melton</surname>
<given-names>LJ III</given-names>
</name>
</person-group>. <article-title>Endometriosis and infertility: a laparoscopic study of endometriosis among fertile and infertile women</article-title>. <source>Fertil Steril</source>. <year>1982</year>;<volume>38</volume>(<issue>6</issue>):<fpage>667</fpage>–<lpage>672</lpage>.</citation>
</ref>
<ref id="bibr4-1933719112466307">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giudice</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Kao</surname>
<given-names>LC</given-names>
</name>
</person-group>. <article-title>Endometriosis</article-title>. <source>Lancet</source>. <year>2004</year>;<volume>364</volume>(<issue>9447</issue>):<fpage>1789</fpage>–<lpage>1799</lpage>.</citation>
</ref>
<ref id="bibr5-1933719112466307">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tummon</surname>
<given-names>IS</given-names>
</name>
<name>
<surname>Maclin</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Radwanska</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Binor</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Dmowski</surname>
<given-names>WP</given-names>
</name>
</person-group>. <article-title>Occult ovulatory dysfunction in women with minimal endometriosis or unexplained infertility</article-title>. <source>Fertil Steril</source>. <year>1988</year>;<volume>50</volume>(<issue>5</issue>):<fpage>716</fpage>–<lpage>720</lpage>.</citation>
</ref>
<ref id="bibr6-1933719112466307">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simón</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gutiérrez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vidal</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Outcome of patients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocyte donation</article-title>. <source>Hum Reprod</source>. <year>1994</year>;<volume>9</volume>(<issue>4</issue>):<fpage>725</fpage>–<lpage>729</lpage>.</citation>
</ref>
<ref id="bibr7-1933719112466307">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ulukus</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cakmak</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Arici</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>The role of endometrium in endometriosis</article-title>. <source>J Soc Gynecol Investig</source>. <year>2006</year>;<volume>13</volume>(<issue>7</issue>):<fpage>467</fpage>–<lpage>476</lpage>.</citation>
</ref>
<ref id="bibr8-1933719112466307">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giudice</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Telles</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Lobo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kao</surname>
<given-names>L</given-names>
</name>
</person-group>. <article-title>The molecular basis for implantation failure in endometriosis: on the road to discovery</article-title>. <source>Ann N Y Acad Sci</source>. <year>2002</year>;<volume>955</volume>:<fpage>252</fpage>–<lpage>264</lpage>.</citation>
</ref>
<ref id="bibr9-1933719112466307">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Somigliana</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Vercellini</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Viganó</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ragni</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Crosignani</surname>
<given-names>PG</given-names>
</name>
</person-group>. <article-title>Should endometriomas be treated before IVF-ICSI cycles?</article-title> <source>Hum Reprod Update</source>. <year>2006</year>;<volume>12</volume>(<issue>1</issue>):<fpage>57</fpage>–<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr10-1933719112466307">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Demirol</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Guven</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Baykal</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gurgan</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Effect of endometrioma cystectomy on IVF outcome: a prospective randomized study</article-title>. <source>Reprod Biomed Online</source>. <year>2006</year>;<volume>12</volume>(<issue>5</issue>):<fpage>639</fpage>–<lpage>643</lpage>.</citation>
</ref>
<ref id="bibr11-1933719112466307">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Var</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Batioglu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tonguc</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kahyaoglu</surname>
<given-names>I</given-names>
</name>
</person-group>. <article-title>The effect of laparoscopic ovarian cystectomy versus coagulation in bilateral endometriomas on ovarian reserve as determined by antral follicle count and ovarian volume: a prospective randomized study</article-title>. <source>Fertil Steril</source>. <year>2011</year>;<volume>95</volume>(<issue>7</issue>):<fpage>2247</fpage>–<lpage>2250</lpage>.</citation>
</ref>
<ref id="bibr12-1933719112466307">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loo</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>SH</given-names>
</name>
<etal/>
</person-group>. <article-title>Endometrioma undergoing laparoscopic ovarian cystectomy: its influence on the outcome of in vitro fertilization and embryo transfer (IVF-ET)</article-title>. <source>J Assist Reprod Genet</source>. <year>2005</year>;<volume>22</volume>(<issue>9-10</issue>):<fpage>329</fpage>–<lpage>333</lpage>.</citation>
</ref>
<ref id="bibr13-1933719112466307">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alborzi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Momtahan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Parsanezhad</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Dehbashi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zolghadri</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Alborzi</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>A prospective, randomized study comparing laparoscopic ovarian cystectomy versus fenestration and coagulation in patients with endometriomas</article-title>. <source>Fertil Steril</source>. <year>2004</year>;<volume>82</volume>(<issue>6</issue>):<fpage>1633</fpage>–<lpage>1637</lpage>.</citation>
</ref>
<ref id="bibr14-1933719112466307">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Celik</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Hascalik</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Elter</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tagluk</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Gurates</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Aydin</surname>
<given-names>NE</given-names>
</name>
</person-group>. <article-title>Combating endometriosis by blocking proteasome and nuclear factor-kappaB pathways</article-title>. <source>Hum Reprod</source>. <year>2008</year>;<volume>23</volume>(<issue>11</issue>):<fpage>2458</fpage>–<lpage>2465</lpage>.</citation>
</ref>
<ref id="bibr15-1933719112466307">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Geng</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>SW</given-names>
</name>
</person-group>. <article-title>The role of nuclear factor-kappa-B p50 subunit in the development of endometriosis</article-title>. <source>Front Biosci (Elite Ed)</source>. <year>2011</year>;<volume>3</volume>:<fpage>591</fpage>–<lpage>603</lpage>.</citation>
</ref>
<ref id="bibr16-1933719112466307">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>SW.</given-names>
</name>
</person-group> <article-title>Immunoreactivity of progesterone receptor isoform B and nuclear factor kappa-B as biomarkers for recurrence of ovarian endometriomas</article-title>. <source>Am J Obstet Gynecol</source>. <year>2008</year>;<volume>199</volume>(<issue>5</issue>):486.<fpage>e1</fpage>–<lpage>486</lpage>.e10.</citation>
</ref>
<ref id="bibr17-1933719112466307">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Novak</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Cocks</surname>
<given-names>BG</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>JA</given-names>
</name>
</person-group>. <article-title>A labile repressor acts through the NFkB-like binding sites of the human urokinase gene</article-title>. <source>Nucleic Acids Res</source>. <year>1991</year>;<volume>19</volume>(<issue>12</issue>):<fpage>3389</fpage>–<lpage>3393</lpage>.</citation>
</ref>
<ref id="bibr18-1933719112466307">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aggarwal</surname>
<given-names>BB</given-names>
</name>
</person-group>. <article-title>Nuclear factor-kB: the enemy within</article-title>. <source>Cancer Cell</source>. <year>2004</year>;<volume>6</volume>(<issue>3</issue>):<fpage>203</fpage>–<lpage>208</lpage>.</citation>
</ref>
<ref id="bibr19-1933719112466307">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laird</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Tuckerman</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Cork</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>TC</given-names>
</name>
</person-group>. <article-title>Expression of nuclear factor k B in human endometrium; role in the control of interleukin 6 and leukaemia inhibitory factor production</article-title>. <source>Mol Hum Reprod</source>. <year>2000</year>;<volume>6</volume>(<issue>1</issue>):<fpage>34</fpage>–<lpage>40</lpage>.</citation>
</ref>
<ref id="bibr20-1933719112466307">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>King</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Critchley</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>RW</given-names>
</name>
</person-group>. <article-title>The NF-kB pathway in human endometrium and first trimester decidua</article-title>. <source>Mol Hum Reprod</source>. <year>2001</year>;<volume>7</volume>(<issue>2</issue>):<fpage>175</fpage>–<lpage>183</lpage>.</citation>
</ref>
<ref id="bibr21-1933719112466307">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>González-Ramos</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rocco</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rojas</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Physiologic activation of nuclear factor kappa-B in the endometrium during the menstrual cycle is altered in endometriosis patients</article-title>. <source>Fertil Steril</source>. <year>2012</year>;<volume>97</volume>(<issue>3</issue>):<fpage>645</fpage>–<lpage>651</lpage>.</citation>
</ref>
<ref id="bibr22-1933719112466307">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sidell</surname>
<given-names>N</given-names>
</name>
</person-group>. <article-title>RU486-induced growth inhibition of human endometrial cells involves the nuclear factor-kB signaling pathway</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2003</year>;<volume>88</volume>(<issue>2</issue>):<fpage>713</fpage>–<lpage>719</lpage>.</citation>
</ref>
<ref id="bibr23-1933719112466307">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beinke</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ley</surname>
<given-names>SC</given-names>
</name>
</person-group>. <article-title>Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology</article-title>. <source>Biochem J</source>. <year>2004</year>;<volume>382</volume>(<issue>pt 2</issue>):<fpage>393</fpage>–<lpage>409</lpage>.</citation>
</ref>
<ref id="bibr24-1933719112466307">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>Greene</surname>
<given-names>WC</given-names>
</name>
</person-group>. <article-title>Shaping the nuclear action of NF-kappaB</article-title>. <source>Nat Rev Mol Cell Biol</source>. <year>2004</year>;<volume>5</volume>(<issue>5</issue>):<fpage>392</fpage>–<lpage>401</lpage>.</citation>
</ref>
<ref id="bibr25-1933719112466307">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pahl</surname>
<given-names>HL</given-names>
</name>
</person-group>. <article-title>Activators and target genes of Rel/NF kappaB transcription factors</article-title>. <source>Oncogene</source>. <year>1999</year>;<volume>18</volume>(<issue>49</issue>):<fpage>6853</fpage>–<lpage>6866</lpage>. </citation>
</ref>
<ref id="bibr26-1933719112466307">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Renard</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Raes</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>The proinflammatory transcription factor NFkappaB: a potential target for novel therapeutical strategies</article-title>. <source>Cell Biol Toxicol</source>. <year>1999</year>;<volume>15</volume>(<issue>6</issue>):<fpage>341</fpage>–<lpage>344</lpage>.</citation>
</ref>
<ref id="bibr27-1933719112466307">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>QM</given-names>
</name>
</person-group>. <article-title>The IKK NF-kB system: a treasure trove for drug development</article-title>. <source>Nat Rev Drug Discov</source>. <year>2004</year>;<volume>3</volume>(<issue>1</issue>):<fpage>17</fpage>–<lpage>26</lpage>.</citation>
</ref>
<ref id="bibr28-1933719112466307">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffmann</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Baltimore</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Circuitry of nuclear factor kB signaling</article-title>. <source>Immunol Rev</source>. <year>2006</year>;<volume>210</volume>:<fpage>171</fpage>–<lpage>186</lpage>.</citation>
</ref>
<ref id="bibr29-1933719112466307">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noyes</surname>
<given-names>RW</given-names>
</name>
<name>
<surname>Hertig</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Rock</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Dating the endometrial biopsy</article-title>. <source>Am J Obstet Gynecol</source>. <year>1975</year>;<volume>122</volume>(<issue>2</issue>):<fpage>262</fpage>–<lpage>263</lpage>.</citation>
</ref>
<ref id="bibr30-1933719112466307">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ordi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Creus</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ferrer</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Midluteal endometrial biopsy and alphavbeta3 integrin expression in the evaluation of the endometrium in infertility: implications for fecundity</article-title>. <source>Int J Gynecol Pathol</source>. <year>2002</year>;<volume>21</volume>(<issue>3</issue>):<fpage>231</fpage>–<lpage>238</lpage>.</citation>
</ref>
<ref id="bibr31-1933719112466307">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Creus</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ordi</surname>
<given-names>J</given-names>
</name>
</person-group>, <article-title>Fábregues F, et al. alphavbeta3 integrin expression and pinopod formation in normal and out-of-phase endometria of fertile and infertile women</article-title>. <source>Hum Reprod</source>. <year>2002</year>;<volume>17</volume>(<issue>9</issue>):<fpage>2279</fpage>–<lpage>2286</lpage>.</citation>
</ref>
<ref id="bibr32-1933719112466307">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Budwit-Novotny</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>McCarty</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>EB</given-names>
</name>
<etal/>
</person-group>. <article-title>Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody</article-title>. <source>Cancer Res</source>. <year>1986</year>;<volume>46</volume>(<issue>10</issue>):<fpage>5419</fpage>–<lpage>5425</lpage>.</citation>
</ref>
<ref id="bibr33-1933719112466307">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lessey</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Castelbaum</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Sawin</surname>
<given-names>SW</given-names>
</name>
<etal/>
</person-group>. <article-title>Aberrant integrin expression in the endometrium of women with endometriosis</article-title>. <source>J Clin Endocrinol Metab</source>. <year>1994</year>;<volume>79</volume>(<issue>2</issue>):<fpage>643</fpage>–<lpage>649</lpage>.</citation>
</ref>
<ref id="bibr34-1933719112466307">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ponce</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Torres</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Galleguillos</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Nuclear factor kappaB pathway and interleukin-6 are affected in eutopic endometrium of women with endometriosis</article-title>. <source>Reproduction</source>. <year>2009</year>;<volume>137</volume>(<issue>4</issue>):<fpage>727</fpage>–<lpage>737</lpage>.</citation>
</ref>
<ref id="bibr35-1933719112466307">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKay</surname>
<given-names>LI</given-names>
</name>
<name>
<surname>Cidlowski</surname>
<given-names>JA</given-names>
</name>
</person-group>. <article-title>Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism</article-title>. <source>Mol Endocrinol</source>. <year>1998</year>;<volume>12</volume>(<issue>1</issue>):<fpage>45</fpage>–<lpage>56</lpage>.</citation>
</ref>
<ref id="bibr36-1933719112466307">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Metzger</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Olive</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Haney</surname>
<given-names>AF</given-names>
</name>
</person-group>. <article-title>Limited hormonal responsiveness of ectopic endometrium: histologic correlation with intrauterine endometrium</article-title>. <source>Hum Pathol</source>. <year>1988</year>;<volume>19</volume>(<issue>12</issue>):<fpage>1417</fpage>–<lpage>1424</lpage>.</citation>
</ref>
<ref id="bibr37-1933719112466307">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burney</surname>
<given-names>RO</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Aghajanova</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>MicroRNA expression profiling of eutopic secretory endometrium in women with versus without endometriosis</article-title>. <source>Mol Hum Reprod</source>. <year>2009</year>;<volume>15</volume>(<issue>10</issue>):<fpage>625</fpage>–<lpage>631</lpage>.</citation>
</ref>
<ref id="bibr38-1933719112466307">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Achache</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Revel</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Endometrial receptivity markers, the journey to successful embryo implantation</article-title>. <source>Hum Reprod Update</source>. <year>2006</year>;<volume>12</volume>(<issue>6</issue>):<fpage>731</fpage>–<lpage>746</lpage>.</citation>
</ref>
<ref id="bibr39-1933719112466307">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Arici</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Olive</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Igarashi</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium</article-title>. <source>J Clin Invest</source>. <year>1998</year>;<volume>101</volume>(<issue>7</issue>):<fpage>1379</fpage>–<lpage>1384</lpage>.</citation>
</ref>
<ref id="bibr40-1933719112466307">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Igarashi</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Olive</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Arici</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Sex steroids mediate HOXA11 expression in the human peri-implantation endometrium</article-title>. <source>J Clin Endocrinol Metab</source>. <year>1999</year>;<volume>84</volume>(<issue>3</issue>):<fpage>1129</fpage>–<lpage>1135</lpage>.</citation>
</ref>
<ref id="bibr41-1933719112466307">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cakmak</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>HS</given-names>
</name>
</person-group>. <article-title>Molecular mechanisms of treatment resistance in endometriosis: the role of progesterone-hox gene interactions</article-title>. <source>Semin Reprod Med</source>.<year>2010</year>;<volume>28</volume>(<issue>1</issue>):<fpage>69</fpage>–<lpage>74</lpage>.</citation>
</ref>
<ref id="bibr42-1933719112466307">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Halverson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Basir</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Strawn</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>SW</given-names>
</name>
</person-group>. <article-title>Aberrant methylation at HOXA10 may be responsible for its aberrant expression in the endometrium of patients with endometriosis</article-title>. <source>Am J Obstet Gynecol</source>. <year>2005</year>;<volume>193</volume>(<issue>2</issue>):<fpage>371</fpage>–<lpage>380</lpage>.</citation>
</ref>
<ref id="bibr43-1933719112466307">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Altered expression of HOXA10 in endometriosis: potential role in decidualization</article-title>. <source>Mol Hum Reprod</source>. <year>2007</year>;<volume>13</volume>(<issue>5</issue>):<fpage>323</fpage>–<lpage>332</lpage>.</citation>
</ref>
<ref id="bibr44-1933719112466307">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>HS</given-names>
</name>
</person-group>. <article-title>Experimental murine endometriosis induces DNA methylation and altered gene expression in eutopic endometrium</article-title>. <source>Biol Reprod</source>. <year>2009</year>;<volume>80</volume>(<issue>1</issue>):<fpage>79</fpage>–<lpage>85</lpage>.</citation>
</ref>
<ref id="bibr45-1933719112466307">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Herceg</surname>
<given-names>Z</given-names>
</name>
</person-group>. <article-title>From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms</article-title>. <source>Genome Med</source>. <year>2012</year>;<volume>4</volume>(<issue>1</issue>):<fpage>8</fpage>.</citation>
</ref>
<ref id="bibr46-1933719112466307">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hartnett</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Egan</surname>
<given-names>LJ</given-names>
</name>
</person-group>. <article-title>Inflammation, DNA methylation and colitis-associated cancer</article-title>. <source>Carcinogenesis</source>. <year>2012</year>;<volume>33</volume>(<issue>4</issue>):<fpage>723</fpage>–<lpage>731</lpage>.</citation>
</ref>
<ref id="bibr47-1933719112466307">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lynch</surname>
<given-names>VJ</given-names>
</name>
<name>
<surname>Brayer</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Gellersen</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>GP</given-names>
</name>
</person-group>, <article-title>HoxA-11 and FOXO1A cooperate to regulate decidual prolactin expression: towards interferring the core transcriptional regulators of decidual genes</article-title>. <source>PLoS ONE</source>, <year>2009</year>;<volume>4</volume>:<fpage>e6845</fpage>.</citation>
</ref>
<ref id="bibr48-1933719112466307">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ben-Jonathan</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Mershon</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Steinmetz</surname>
<given-names>RW</given-names>
</name>
</person-group>. <article-title>Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects</article-title>. <source>Endocr Rev</source>. <year>1996</year>;<volume>17</volume>(<issue>6</issue>):<fpage>639</fpage>–<lpage>669</lpage>.</citation>
</ref>
<ref id="bibr49-1933719112466307">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jabbour</surname>
<given-names>HN</given-names>
</name>
<name>
<surname>Critchley</surname>
<given-names>HO</given-names>
</name>
</person-group>. <article-title>Potential roles of decidual prolactin in early pregnancy</article-title>. <source>Reproduction</source>. <year>2001</year>;<volume>121</volume>(<issue>2</issue>):<fpage>197</fpage>–<lpage>205</lpage>.</citation>
</ref>
<ref id="bibr50-1933719112466307">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strandell</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lindhard</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Waldenström</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Thorburn</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Hydrosalpinx and IVF outcome: cumulative results after salpingectomy in a randomized controlled trial</article-title>. <source>Hum Reprod</source>. <year>2001</year>;<volume>16</volume>(<issue>11</issue>):<fpage>2403</fpage>–<lpage>2410</lpage>.</citation>
</ref>
<ref id="bibr51-1933719112466307">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnson</surname>
<given-names>NP</given-names>
</name>
<name>
<surname>Mak</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Sowter</surname>
<given-names>MC.</given-names>
</name>
</person-group> <article-title>Surgical treatment for tubal disease in women due to undergo in vitro fertilisation</article-title>. <source>Cochrane Database Syst Rev</source>. <year>2004</year>;(<issue>3</issue>):<fpage>CD002125</fpage>.</citation>
</ref>
<ref id="bibr52-1933719112466307">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cermik</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Selam</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>HS</given-names>
</name>
</person-group>. <article-title>Regulation of HOXA 10 expression by testosterone in vitro and in the endometrium of patients with polycystic ovary syndrome</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2003</year>;<volume>88</volume>(<issue>1</issue>):<fpage>238</fpage>–<lpage>243</lpage>.</citation>
</ref>
<ref id="bibr53-1933719112466307">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rackow</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>HS</given-names>
</name>
</person-group>. <article-title>Submucosal uterine leiomyomas have a global effect on molecular determinants of endometrial receptivity</article-title>. <source>Fertil Steril</source>. <year>2010</year>;<volume>93</volume>(<issue>6</issue>):<fpage>2027</fpage>–<lpage>2034</lpage>.</citation>
</ref>
<ref id="bibr54-1933719112466307">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klemmt</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Carver</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Koninckx</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Mardon</surname>
<given-names>HJ</given-names>
</name>
</person-group>. <article-title>Stromal cells from endometriotic lesions and endometrium from women with endometriosis have reduced decidualization capacity</article-title>. <source>Fertil Steril</source>. <year>2006</year>;<volume>85</volume>(<issue>3</issue>):<fpage>564</fpage>–<lpage>572</lpage>.</citation>
</ref>
<ref id="bibr55-1933719112466307">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vitiello</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kodaman</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>HS</given-names>
</name>
</person-group>. <article-title>HOX genes in implantation</article-title>. <source>Semin Reprod Med</source>. <year>2007</year>;<volume>25</volume>(<issue>6</issue>):<fpage>431</fpage>–<lpage>436</lpage>.</citation>
</ref>
<ref id="bibr56-1933719112466307">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daftary</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Kayisli</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Seli</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bukulmez</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Arici</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>HS</given-names>
</name>
</person-group>. <article-title>Salpingectomy increases peri implantation endometrial HOXA10 expression in women with hydrosalpinx</article-title>. <source>Fertil Steril</source>. <year>2007</year>;<volume>87</volume>(<issue>2</issue>):<fpage>367</fpage>–<lpage>372</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>